---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-015482"
form_type: "8-K"
ticker: "CAPR"
cik: "0001133869"
company_name: "CAPRICOR THERAPEUTICS, INC."
filed_at: "2023-09-06T23:59:59+00:00"
generated_at: "2026-06-10T23:13:57.655290+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Capricor Therapeutics appoints Michael Kelliher to Board of Directors

## Summary
- Michael Kelliher appointed to Board effective September 1, 2023; Board size increased from 8 to 9.
- Kelliher is Group VP of M&A and Business Development at Horizon Therapeutics; 20+ years biotech/pharma experience.
- Receives initial nonstatutory stock option for 115,000 shares vesting over 3 years (25% at 1 year, then monthly).
- Will enter standard indemnification agreement; no committees assigned initially.

## SEC filing metadata
- accession: 0001558370-23-015482
- form_type: 8-K
- ticker: CAPR
- cik: 0001133869
- company_name: CAPRICOR THERAPEUTICS, INC.
- filed_at: 2023-09-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1133869/000155837023015482/0001558370-23-015482-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1133869/000155837023015482/capr-20230901x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-015482
- JSON: https://secwatch.observer/filing/0001558370-23-015482.json
- Plain text: https://secwatch.observer/filing/0001558370-23-015482.txt

## Key facts
- Executive change
  Michael Kelliher was elected as Director at CAPRICOR THERAPEUTICS, INC..
  - Action: elected
  - Role: Director
  source text: On September 1, 2023, the Board of Directors (the “Board”) of Capricor Therapeutics, Inc. (the “Company”), pursuant to the authority given to it under the Certificate of Incorporation and Bylaws of the Company, approved an increase of the size of the Board from eight to nine directors, and thereafter elected Michael Kelliher as a member of the Board to fill the newly created vacancy, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1133869/000155837023015482/0001558370-23-015482-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.